{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:57:51Z","timestamp":1785250671618,"version":"3.55.0"},"reference-count":64,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T00:00:00Z","timestamp":1455667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Testing and Analysis"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:p>Drug testing is a harm reduction strategy that has been adopted by certain countries in Europe. Drug users are able to hand in their drugs voluntarily for chemical analysis of composition and dose. Drug users will be alerted about dangerous test results by the drug testing systems directly and through warning campaigns. An international collaborative effort was launched to combine data of drug testing systems, called the Trans European Drug Information (TEDI) project. Drug testing systems of Spain, Switzerland, Belgium, Austria, Portugal, and the Netherlands participated in this project. This study presents results of some of the main illicit drugs encountered: cocaine, ecstasy and amphetamine and also comments on new psychoactive substances (NPS) detected between 2008 and 2013. A total of 45 859 different drug samples were analyzed by TEDI. The drug markets of the distinct European areas showed similarities, but also some interesting differences. For instance, purity of cocaine and amphetamine powders was generally low in Austria, whilst high in Spain and the Netherlands. And the market for ecstasy showed a contrast: whereas in the Netherlands and Switzerland there was predominantly a market for ecstasy tablets, in Portugal and Spain MDMA (3,4\u2010methylenedioxymethamphetamine) crystals were much more prevalent. Also, some NPS appearing in ecstasy seemed more specific for one country than another. In general, prevalence of NPS clearly increased between 2008 and 2013. Drug testing can be used to generate a global picture of drug markets and provides information about the pharmacological contents of drugs for the population at risk. Copyright \u00a9 2016 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/dta.1954","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T14:31:17Z","timestamp":1455805877000},"page":"188-198","source":"Crossref","is-referenced-by-count":155,"title":["Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project"],"prefix":"10.1002","volume":"9","author":[{"given":"Tibor M.","family":"Brunt","sequence":"first","affiliation":[{"name":"Drug Information and Monitoring System (DIMS) Netherlands Institute of Mental Health and Addiction (Trimbos Institute)  Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Nagy","sequence":"additional","affiliation":[{"name":"Checkit! \u2013 Suchthilfe Wien GmbH  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"B\u00fccheli","sequence":"additional","affiliation":[{"name":"Safer Nightlife Switzerland  Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martins","sequence":"additional","affiliation":[{"name":"Ag\u00eancia Piaget para o Desenvolvimento (APDES)  V. N. Gaia Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Ugarte","sequence":"additional","affiliation":[{"name":"Ai Laket  Vitoria\u2010Gasteiz Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Beduwe","sequence":"additional","affiliation":[{"name":"Modus Vivendi ASBL, Harm Reduction among drug users  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Ventura Vilamala","sequence":"additional","affiliation":[{"name":"Energy Control\u2010 Asociaci\u00f3n Bienestar y Desarrollo  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,17]]},"reference":[{"key":"e_1_2_6_2_1","volume-title":"Illegal Leisure: The Normalization of Adolescent Recreational Drug Use","author":"Parker H. J.","year":"1998"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204269902900303"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/her\/16.4.457"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050709"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.04.003"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.346"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2466"},{"key":"e_1_2_6_9_1","unstructured":"EMCDDA.European Drug Report 2015. EMCDDA Lisbon 2015."},{"key":"e_1_2_6_10_1","unstructured":"Mixmag.Global Drug Survey 2014. Mixmag London 2014."},{"key":"e_1_2_6_11_1","unstructured":"F.Goossens T.Frijns N.vanHasselt M.vanLaar.Het Grote Uitgaansonderzoek 2013. Utrecht Trimbos Institute 2014."},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4603(02)00271-X"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(99)00205-2"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1081\/JA-100000227"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1712-7"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2529-4"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204269902900312"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.323"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13698570802160913"},{"key":"e_1_2_6_20_1","unstructured":"H.Kriener R.Smid G.Smekal.An inventory of on\u2010site pill\u2010testing interventions in the European Union. Vienna Social Projects. EMCDDA Lisbon 2001."},{"key":"e_1_2_6_21_1","unstructured":"A.Benschop M.Rabes D.J.Korf.Pill Testing Ecstasy & Prevention. Rozenberg Amsterdam 2002."},{"key":"e_1_2_6_22_1","first-page":"38","article-title":"Evaluation of Party Drug Prevention in the City of Zurich","volume":"5","author":"B\u00fccheli A.","year":"2010","journal-title":"Suchtmagazin"},{"key":"e_1_2_6_23_1","first-page":"61","article-title":"Testeo y an\u00e1lisis de sustancias como pr\u00e1ctica para una reducci\u00f3n de riesgos","volume":"16","author":"Rovira J.","year":"2002","journal-title":"Eguzkilore: Cuaderno del Instituto Vasco de Criminolog\u00eda."},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0104-12902015000200020"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826080701212428"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.11.016"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02532.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2010.03.004"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02707.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000180227.04137.3c"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2004.07.004"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111431752"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110378370"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2014.05.005"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(98)00102-9"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(02)00419-X"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS2003401"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1355-0306(06)71588-X"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2009.03.004"},{"key":"e_1_2_6_40_1","unstructured":"A.Benschop D.J.Korf.Bezoekers van de Jellinek testservice: Gebruikspatronen en beoordeling van de testservice in 2008 en 2011. Bonger Instituut voor Criminologie Amsterdam 2012."},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-8-16"},{"key":"e_1_2_6_42_1","doi-asserted-by":"crossref","unstructured":"D.Allemann H.Pauli A.M\u00fcrner H.J.Helmlin S.Steiner.Substance Testing on the Dance Floor with a Mobile High\u2010tech Lab. Poster Club Health Z\u00fcrich 2010.","DOI":"10.2533\/chimia.2010.668"},{"key":"e_1_2_6_43_1","unstructured":"United Nations Office on Drugs and Crime (UNODC).World Drug Report 2014. United Nations Vienna 2014."},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/13556210500350794"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109102541"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12932"},{"key":"e_1_2_6_47_1","unstructured":"United Nations Office on Drugs and Crime (UNODC).The Challenge of New Psychoative Substances. United Nations Vienna 2013."},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112474525"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1686"},{"key":"e_1_2_6_50_1","unstructured":"European Commission.Drug precursors: EU summary report 2012. European Commission Brussels 2012."},{"key":"e_1_2_6_51_1","unstructured":"United Nations Office on Drugs and Crime (UNODC).Global Synthetic Drugs assessment. United Nations Vienna 2014."},{"key":"e_1_2_6_52_1","first-page":"102","article-title":"Dermatologic complications from levamisole\u2010contaminated cocaine: a case report and review of the literature","volume":"93","author":"Gaertner E. M.","year":"2014","journal-title":"Cutis"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm1008722"},{"key":"e_1_2_6_54_1","first-page":"1","article-title":"Vasculopathy related to cocaine adulterated with levamisole: A review of the literature","volume":"18","author":"Pearson T.","year":"2012","journal-title":"Dermat. Online"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30590"},{"key":"e_1_2_6_56_1","unstructured":"National Institute for Public Health and the Environment.Quick Scan Report levamisole. RIVM Bilthoven 2014."},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113487950"},{"key":"e_1_2_6_58_1","unstructured":"EMCDDA.New Psychoactive Substances in Europe. EMCDDA Lisbon 2015."},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1610"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.11.033"},{"key":"e_1_2_6_61_1","unstructured":"EMCDDA.EMCDDA\u2013Europol Joint Report on a new psychoactive substance: 1\u2010phenyl\u20102\u2010(1\u2010pyrrolidinyl)\u2010 1\u2010pentanone (\u03b1\u2010PVP). EMCDDA Lisbon 2015."},{"key":"e_1_2_6_62_1","unstructured":"EMCDDA.EMCDDA\u2013Europol Joint Report on a new psychoactive substance: 4 4\u2032\u2010DMAR (4\u2010methyl\u20105\u2010 (4\u2010methylphenyl)\u20104 5\u2010dihydrooxazol\u20102\u2010amine). EMCDDA Lisbon 2014."},{"key":"e_1_2_6_63_1","unstructured":"EMCDDA.Report on the risk assessment of 5\u2010(2\u2010aminopropyl)indole in the framework of the Council Decision on new psychoactive substances.EMCDDA Lisbon 2014."},{"key":"e_1_2_6_64_1","unstructured":"BEWSD.September 2015 \u2010 Neurotoxic new substance found in ecstasy tablet. BEWSD Brussels 2015."},{"key":"e_1_2_6_65_1","unstructured":"The Guardian.PMMA found in 'Superman' ecstasy possibly linked to four deaths. Press Association The Guardian London January2015."}],"container-title":["Drug Testing and Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdta.1954","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdta.1954","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.1954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T22:46:56Z","timestamp":1760395616000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/dta.1954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,17]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1002\/dta.1954"],"URL":"https:\/\/doi.org\/10.1002\/dta.1954","archive":["Portico"],"relation":{},"ISSN":["1942-7603","1942-7611"],"issn-type":[{"value":"1942-7603","type":"print"},{"value":"1942-7611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,17]]}}}